This project will study the incorporation of individual patient related geometric uncertainties in the calculation,compilation and treatment of optimized radiotherapy dose distributions. Even advanced treatment planningtechniques nearly always rely on population-based rules to ensure that the majority of patients receiveadequate dose in the face of positioning errors and organ motion. This 'one size fits all' approach potentiallypenalizes patients who exhibit exceptionally large variation in position or motion, requiring more intensivemeasures to ensure adequate target volume coverage. However, it also penalizes a substantial proportion ofpatients with less uncertainty in their target position, who through the use of smaller margins would be atlesser risk for treatment related toxicity or eligible for higher tumor dose. We believe that a new combinedapproach involving a) dose computation strategies that already include the effects of geometric uncertainties,b) rigorous in-room methodologies for rapidly assessing target and patient configuration and c) accountingfor delivered dose and its influence on subsequent treatment delivery optimization will yield improvementsin efficient and accurate dose delivery, optimally tailored for each patient. Thus, the project's specific aims areto 1) implement general clinical frameworks for inclusion of patient related setup uncertainties and organmotion into the computation of dose distributions, 2) assess improvements in accuracy achieved through inroom,on-treatment measurement and action, 3) investigate human anatomic changes over short and longtime periods and how to accumulate dose to date using this information, and 4) determine the best ways toreact to differences between what is seen at treatment and what had been planned. In addition to bettertailoring overall treatments, these investigations will help determine how much complexity (in modeling,measurement and intervention) is actually beneficial for a given patient, thus helping to establish the mostefficient use of advanced in-room imaging resources within the radiotherapy community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA059827-11A1
Application #
7082532
Study Section
Subcommittee G - Education (NCI)
Project Start
2006-04-01
Project End
2011-06-30
Budget Start
2006-04-01
Budget End
2007-06-30
Support Year
11
Fiscal Year
2006
Total Cost
$254,780
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kong, Feng-Ming Spring; Li, Ling; Wang, Weili et al. (2018) Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol :
Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela et al. (2018) Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol 41:326-331
Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal et al. (2018) Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 100:950-958
Miften, Moyed; Vinogradskiy, Yevgeniy; Moiseenko, Vitali et al. (2018) Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys :
Konerman, Matthew C; Lazarus, John J; Weinberg, Richard L et al. (2018) Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation. Circ Heart Fail 11:e004473
Tseng, Huan-Hsin; Wei, Lise; Cui, Sunan et al. (2018) Machine Learning and Imaging Informatics in Oncology. Oncology :1-19
El Naqa, Issam; Ruan, Dan; Valdes, Gilmer et al. (2018) Machine learning and modeling: Data, validation, communication challenges. Med Phys 45:e834-e840
El Naqa, Issam; Johansson, Adam; Owen, Dawn et al. (2018) Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:335-343
Wang, Weili; Huang, Lei; Jin, Jian-Yue et al. (2018) IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients. Cancer Res 78:809-816
Suresh, Krithika; Owen, Dawn; Bazzi, Latifa et al. (2018) Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:131-137

Showing the most recent 10 out of 289 publications